Nuts and bolts of the salt-inducible kinases (SIKs).

AMPK-related kinase CREB CREB-regulated transcriptional co-activator (CRTC) histone deacetylase (HDAC) myocyte enhancer factor 2 (MEF2) salt-inducible kinase (SIK)

Journal

The Biochemical journal
ISSN: 1470-8728
Titre abrégé: Biochem J
Pays: England
ID NLM: 2984726R

Informations de publication

Date de publication:
16 04 2021
Historique:
received: 01 03 2021
revised: 29 03 2021
accepted: 31 03 2021
entrez: 16 4 2021
pubmed: 17 4 2021
medline: 14 9 2021
Statut: ppublish

Résumé

The salt-inducible kinases, SIK1, SIK2 and SIK3, most closely resemble the AMP-activated protein kinase (AMPK) and other AMPK-related kinases, and like these family members they require phosphorylation by LKB1 to be catalytically active. However, unlike other AMPK-related kinases they are phosphorylated by cyclic AMP-dependent protein kinase (PKA), which promotes their binding to 14-3-3 proteins and inactivation. The most well-established substrates of the SIKs are the CREB-regulated transcriptional co-activators (CRTCs), and the Class 2a histone deacetylases (HDAC4/5/7/9). Phosphorylation by SIKs promotes the translocation of CRTCs and Class 2a HDACs to the cytoplasm and their binding to 14-3-3s, preventing them from regulating their nuclear binding partners, the transcription factors CREB and MEF2. This process is reversed by PKA-dependent inactivation of the SIKs leading to dephosphorylation of CRTCs and Class 2a HDACs and their re-entry into the nucleus. Through the reversible regulation of these substrates and others that have not yet been identified, the SIKs regulate many physiological processes ranging from innate immunity, circadian rhythms and bone formation, to skin pigmentation and metabolism. This review summarises current knowledge of the SIKs and the evidence underpinning these findings, and discusses the therapeutic potential of SIK inhibitors for the treatment of disease.

Identifiants

pubmed: 33861845
pii: 228393
doi: 10.1042/BCJ20200502
pmc: PMC8057676
doi:

Substances chimiques

Protein Kinase Inhibitors 0
Protein Serine-Threonine Kinases EC 2.7.11.1
SIK1 protein, human EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1377-1397

Subventions

Organisme : Medical Research Council
ID : MR/R021406/1
Pays : United Kingdom

Informations de copyright

© 2021 The Author(s).

Références

Nature. 2006 Sep 21;443(7109):340-4
pubmed: 16988713
Biochem J. 2015 Jan 15;465(2):271-9
pubmed: 25351958
Science. 2002 Dec 6;298(5600):1912-34
pubmed: 12471243
ACS Chem Biol. 2016 Aug 19;11(8):2105-11
pubmed: 27224444
J Clin Invest. 2010 Jul;120(7):2355-69
pubmed: 20577053
Neuron. 2002 Mar 28;34(1):13-25
pubmed: 11931738
N Engl J Med. 2001 May 10;344(19):1434-41
pubmed: 11346808
Development. 2012 Mar;139(6):1153-63
pubmed: 22318228
Elife. 2017 Dec 11;6:
pubmed: 29227248
Nat Commun. 2014 Aug 04;5:4535
pubmed: 25088745
J Biol Chem. 2015 Jul 17;290(29):17879-17893
pubmed: 26048985
J Intern Med. 2014 Dec;276(6):543-59
pubmed: 24824502
J Biol Chem. 2014 Jul 25;289(30):21108-19
pubmed: 24841198
FEBS J. 2018 Feb;285(3):467-480
pubmed: 29211348
Diabetes. 2014 Nov;63(11):3659-73
pubmed: 24898145
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16986-91
pubmed: 23033494
Cell. 2004 Nov 12;119(4):555-66
pubmed: 15537544
Cell. 2004 Oct 1;119(1):61-74
pubmed: 15454081
Trends Endocrinol Metab. 2004 Jan-Feb;15(1):21-6
pubmed: 14693422
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10458-10463
pubmed: 30254177
Cell Rep. 2017 Jun 13;19(11):2177-2184
pubmed: 28614705
FEBS J. 2006 Jun;273(12):2730-48
pubmed: 16817901
J Cell Sci. 2015 Feb 1;128(3):472-86
pubmed: 25472719
EMBO J. 2002 Dec 2;21(23):6539-48
pubmed: 12456660
Biochem J. 2010 Jan 27;426(1):109-18
pubmed: 19958286
J Biol Chem. 1987 Oct 15;262(29):14042-8
pubmed: 2820993
PLoS Biol. 2020 Apr 21;18(4):e3000220
pubmed: 32315298
Cell. 2011 May 13;145(4):596-606
pubmed: 21565616
EMBO J. 2007 Jan 24;26(2):358-70
pubmed: 17170704
Diabetologia. 2013 Sep;56(9):1898-906
pubmed: 23835523
Diabetologia. 2017 Feb;60(2):314-323
pubmed: 27807598
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6669-E6677
pubmed: 28743754
Obesity (Silver Spring). 2008 Mar;16(3):531-8
pubmed: 18239551
J Neurochem. 2000 Jun;74(6):2227-38
pubmed: 10820182
J Biol Chem. 2002 Nov 1;277(44):42334-43
pubmed: 12200423
Nature. 2008 Oct 16;455(7215):894-902
pubmed: 18923511
EMBO J. 2004 Feb 25;23(4):833-43
pubmed: 14976552
Biochem J. 2012 Jun 15;444(3):503-14
pubmed: 22462548
Nat Rev Drug Discov. 2010 Sep;9(9):703-18
pubmed: 20811382
J Mol Endocrinol. 2019 Nov;63(4):R93-R102
pubmed: 31557726
Sci Transl Med. 2018 Sep 19;10(459):
pubmed: 30232230
J Cell Sci. 2002 Jun 1;115(Pt 11):2349-55
pubmed: 12006619
Endocr Res. 2002 Nov;28(4):315-8
pubmed: 12530631
Biochem Pharmacol. 2004 Sep 15;68(6):1221-9
pubmed: 15313420
Biochem J. 2006 Mar 15;394(Pt 3):545-55
pubmed: 16396636
Signal Transduct Target Ther. 2020 Aug 12;5(1):150
pubmed: 32788639
FEBS J. 2015 May;282(9):1736-44
pubmed: 25244360
Biochem J. 2007 Dec 15;408(3):297-315
pubmed: 17850214
Nat Rev Mol Cell Biol. 2011 Mar;12(3):141-51
pubmed: 21346730
Nat Med. 2007 May;13(5):597-603
pubmed: 17468767
J Biol Chem. 2021 Feb 15;:100428
pubmed: 33600797
Mol Metab. 2015 Nov 06;5(1):34-46
pubmed: 26844205
J Neurosci. 2000 Jun 1;20(11):4030-6
pubmed: 10818138
J Sleep Res. 2016 Apr;25(2):131-43
pubmed: 26762182
Front Pharmacol. 2021 Jan 14;11:624429
pubmed: 33519490
J Cell Sci. 2005 Dec 1;118(Pt 23):5661-73
pubmed: 16306228
Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1488-93
pubmed: 17242355
Nature. 2007 Feb 22;445(7130):843-50
pubmed: 17314970
Nature. 2016 Nov 17;539(7629):378-383
pubmed: 27806374
Neuron. 2002 Jan 31;33(3):369-81
pubmed: 11832225
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Biol Psychiatry. 2019 Apr 15;85(8):650-666
pubmed: 30503507
Mol Cell Endocrinol. 2004 Mar 31;217(1-2):109-12
pubmed: 15134808
Nature. 2005 Mar 10;434(7030):243-9
pubmed: 15665823
Blood. 2020 Jan 2;135(1):56-70
pubmed: 31697837
J Leukoc Biol. 2016 May;99(5):711-21
pubmed: 26590148
Mol Cell. 2002 Jan;9(1):45-57
pubmed: 11804585
J Bone Miner Res. 2007 Dec;22(12):1957-67
pubmed: 17696759
Mol Cell Proteomics. 2009 Jul;8(7):1751-64
pubmed: 19369195
J Biol Chem. 1977 Jul 25;252(14):4888-94
pubmed: 194899
J Biol Chem. 2003 Jun 27;278(26):23515-21
pubmed: 12709441
Cell. 2013 Aug 29;154(5):1100-1111
pubmed: 23993098
Science. 2001 Aug 31;293(5535):1653-7
pubmed: 11533489
Adv Immunol. 2014;122:177-210
pubmed: 24507158
J Med Chem. 2006 Aug 10;49(16):4981-91
pubmed: 16884310
J Biol Chem. 2002 Dec 13;277(50):48868-75
pubmed: 12364326
J Neurosci. 1996 Apr 1;16(7):2365-72
pubmed: 8601816
Am J Hum Genet. 2015 Apr 2;96(4):682-90
pubmed: 25839329
Nature. 2007 Sep 20;449(7160):366-9
pubmed: 17805301
Neuron. 2011 Jan 13;69(1):106-19
pubmed: 21220102
Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62
pubmed: 22436748
J Biol Chem. 2003 Jan 24;278(4):2758-66
pubmed: 12419806
Pigment Cell Melanoma Res. 2010 Dec;23(6):809-19
pubmed: 20819186
Cell Metab. 2015 Nov 3;22(5):907-21
pubmed: 26456332
Cell Metab. 2014 Jun 3;19(6):1058-65
pubmed: 24768298
Eur J Immunol. 2011 Sep;41(9):2498-502
pubmed: 21952805
J Biol Chem. 2003 May 16;278(20):18440-7
pubmed: 12624099
Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):20865-70
pubmed: 23213254
Trends Endocrinol Metab. 2018 Dec;29(12):827-840
pubmed: 30385008
J Bone Miner Res. 2011 Feb;26(2):229-38
pubmed: 21254230
Endocr Rev. 2021 Jan 28;42(1):77-96
pubmed: 32897388
Clin Cancer Res. 2017 Apr 15;23(8):1945-1954
pubmed: 27678456
J Photochem Photobiol B. 2001 Oct;63(1-3):8-18
pubmed: 11684447
Nature. 2005 Oct 20;437(7062):1109-11
pubmed: 16148943
Nat Commun. 2016 Oct 19;7:13176
pubmed: 27759007
Cancer Discov. 2019 Nov;9(11):1590-1605
pubmed: 31350327
Cell. 2010 Dec 23;143(7):1174-89
pubmed: 21183079
PLoS One. 2012;7(5):e37803
pubmed: 22662228
Curr Biol. 1996 Sep 1;6(9):1104-13
pubmed: 8805370
Am J Physiol Endocrinol Metab. 2009 Jun;296(6):E1430-9
pubmed: 19351809
J Immunol. 2013 Jan 15;190(2):565-77
pubmed: 23241891
J Proteome Res. 2013 Jan 4;12(1):260-71
pubmed: 23186163
Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):16922-7
pubmed: 17939993
Nat Genet. 1995 Nov;11(3):328-30
pubmed: 7581459
Cell. 1997 Dec 26;91(7):1055-64
pubmed: 9428527
Sci Rep. 2020 May 26;10(1):8676
pubmed: 32457359
Clin Gastroenterol Hepatol. 2006 Jun;4(6):754-9
pubmed: 16716759
J Immunol. 2001 Jun 1;166(11):6861-8
pubmed: 11359846
J Cell Biochem. 2008 Aug 1;104(5):1724-39
pubmed: 18348280
Biol Psychiatry. 2001 May 1;49(9):753-62
pubmed: 11331083
J Clin Invest. 2019 Dec 2;129(12):5187-5203
pubmed: 31430259
PLoS One. 2017 Feb 24;12(2):e0173013
pubmed: 28235073
Eur J Hum Genet. 2017 Feb;25(2):216-221
pubmed: 27966542
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Nat Cell Biol. 2018 Jul;20(7):811-822
pubmed: 29941929
Cell. 2011 May 13;145(4):607-21
pubmed: 21565617
J Bone Miner Res. 2012 Mar;27(3):499-505
pubmed: 22354849
Biochem J. 2011 Feb 15;434(1):93-104
pubmed: 21138416
Cancer Discov. 2019 Nov;9(11):1606-1627
pubmed: 31350328
J Biol Chem. 2010 Nov 12;285(46):35245-8
pubmed: 20880840
EMBO Rep. 2017 Jul;18(7):1166-1185
pubmed: 28588072
Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E671-8
pubmed: 12626323
Biochem J. 2014 Mar 15;458(3):469-79
pubmed: 24438093
Dev Cell. 2007 Mar;12(3):377-89
pubmed: 17336904
FEBS Lett. 1999 Jun 18;453(1-2):135-9
pubmed: 10403390
Mol Endocrinol. 2001 Aug;15(8):1264-76
pubmed: 11463852
Biochem J. 2017 Feb 15;474(4):521-537
pubmed: 27920213
Nat Clin Pract Rheumatol. 2007 Jul;3(7):391-9
pubmed: 17599073
Biochem J. 2004 Jul 15;381(Pt 2):329-42
pubmed: 15167810
Nat Commun. 2016 Mar 24;7:10959
pubmed: 27009967
J Immunol. 1999 Jul 15;163(2):963-9
pubmed: 10395693
Genetics. 2008 Nov;180(3):1475-91
pubmed: 18832350
Nature. 2018 Jun;558(7710):435-439
pubmed: 29899451
Science. 2005 Dec 9;310(5754):1642-6
pubmed: 16308421
Cell Signal. 2012 Sep;24(9):1863-71
pubmed: 22588126
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12468-73
pubmed: 25114223

Auteurs

Nicola J Darling (NJ)

MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, U.K.

Philip Cohen (P)

MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH